Literature DB >> 29408272

Prediction of DNA methylation in the promoter of gene suppressor tumor.

Imane Saif1, Yassine Kasmi1, Karam Allali2, Moulay Mustapha Ennaji3.   

Abstract

The epigenetics methylation of cytosine is the most common epigenetic form in DNA sequences. It is highly concentrated in the promoter regions of the genes, leading to an inactivation of tumor suppressors regardless of their initial function. In this work, we aim to identify the highly methylated regions; the cytosine-phosphate-guanine (CpG) island located on the promoters and/or the first exon gene known for their key roles in the cell cycle, hence the need to study gene-gene interactions. The Frommer and hidden Markov model algorithms are used as computational methods to identify CpG islands with specificity and sensitivity up to 76% and 80%, respectively. The results obtained show, on the one hand, that the genes studied are suspected of developing hypermethylation in the promoter region of the gene involved in the case of a cancer. We then showed that the relative richness in CG results from a high level of methylation. On the other hand, we observe that the gene-gene interaction exhibits co-expression between the chosen genes. This let us to conclude that the hidden Markov model algorithm predicts more specific and valuable information about the hypermethylation in gene as a preventive and diagnostics tools for the personalized medicine; as that the tumor-suppresser-genes have relative co-expression and complementary relations which the hypermethylation affect in the samples studied in our work.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  CpG island; Hidden Markov model; Personalized medicine; Suppressor gene tumor

Mesh:

Substances:

Year:  2018        PMID: 29408272     DOI: 10.1016/j.gene.2018.01.082

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

1.  Prokaryotic and eukaryotic promoters identification based on residual network transfer learning.

Authors:  Xiao Liu; Yuqiao Xu; Yachuan Luo; Li Teng
Journal:  Bioprocess Biosyst Eng       Date:  2022-03-13       Impact factor: 3.210

Review 2.  DNA Methylation as a Therapeutic Target for Bladder Cancer.

Authors:  Sandra P Nunes; Rui Henrique; Carmen Jerónimo; Jesús M Paramio
Journal:  Cells       Date:  2020-08-07       Impact factor: 6.600

3.  Leveraging methylation to identify the potential causal genes associated with survival in lung adenocarcinoma and lung squamous cell carcinoma.

Authors:  Lu Liu; Ping Zeng; Sheng Yang; Zhongshang Yuan
Journal:  Oncol Lett       Date:  2020-04-22       Impact factor: 2.967

4.  Promoter Methylation-Mediated NPTX2 Silencing Promotes Tumor Growth in Human Prostate Cancer.

Authors:  Yixi Su; Qiang Huang; Li Lu; Hu Qu; Dejuan Wang; Jianguang Qiu; Weiqian Li; Mengmeng Lin; Huanliang Liu; Zhongyang Wang; Xiangling Yang
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.